Point72 Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,100
| Closed | -$43.9K | – | 1781 |
|
|
2024
Q2 | $43.9K | Hold |
17,100
| – | – | ﹤0.01% | 1114 |
|
|
2024
Q1 | $84.1K | Buy |
+17,100
| New | +$84.1K | ﹤0.01% | 1312 |
|
|
2023
Q4 | – | Sell |
-1,363,168
| Closed | -$15.6M | – | 2220 |
|
|
2023
Q3 | $15.6M | Buy |
1,363,168
+686,735
| +102% | +$7.88M | 0.05% | 434 |
|
|
2023
Q2 | $17.1M | Buy |
+676,433
| New | +$17.1M | 0.05% | 387 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2054 |
|
|
2022
Q3 | – | Sell |
-605,574
| Closed | -$8.37M | – | 1430 |
|
|
2022
Q2 | $8.37M | Sell |
605,574
-181,393
| -23% | -$2.51M | 0.04% | 490 |
|
|
2022
Q1 | $15.3M | Sell |
786,967
-94,515
| -11% | -$1.84M | 0.06% | 361 |
|
|
2021
Q4 | $14.4M | Buy |
881,482
+126,682
| +17% | +$2.07M | 0.06% | 394 |
|
|
2021
Q3 | $21M | Buy |
+754,800
| New | +$21M | 0.09% | 276 |
|
|
2021
Q2 | – | Sell |
-268,400
| Closed | -$7.5M | – | 1146 |
|
|
2021
Q1 | $7.5M | Buy |
+268,400
| New | +$7.5M | 0.04% | 468 |
|
|
2020
Q1 | – | Sell |
-265,199
| Closed | -$4.3M | – | 1094 |
|
|
2019
Q4 | $4.3M | Buy |
265,199
+47,044
| +22% | +$763K | 0.02% | 488 |
|
|
2019
Q3 | $2.84M | Buy |
218,155
+102,455
| +89% | +$1.33M | 0.02% | 503 |
|
|
2019
Q2 | $1.5M | Buy |
+115,700
| New | +$1.5M | 0.01% | 623 |
|